Condition
Mycobacterium Tuberculosis Infection
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (2)
P 3 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05285202Not ApplicableRecruiting
Clinic-based Versus Hotspot-focused Active TB Case Finding
NCT04493671Phase 1Completed
Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
NCT04351685Phase 3CompletedPrimary
Evaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in Infants
NCT05526911Phase 1Completed
A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults
Showing all 4 trials